Our analysis of MYCN-amplified NBL cell line and O-PDX models has revealed substantial variations in their promoter activities, which is a potential caveat to the practice of surrogate model (representing primary tumor epigenomes by a few profiled models). The gene discussed is MYCN; the disease is neoplasm.